Skip to research content
Back to companies
AcouSort AB logo

AcouSort AB

Last 12 months

EUR

Net buy/sell balance
€0.00
Public filings
0
Reported buys
€0.00
Reported sales
€0.00
Total reported value
€0.00
Other reported value
€0.00

Activity uses publication dates. This selector changes the chart only; the summary above shows the last 12 months.

Insider trades and share price

Monthly filing activity by publication date and share price, shown for context.

Insider filing data is still loading. Historical price data is still loading.

Loading chart data

Insider activity and price evolution

Signals Pro

Price change after the observation · 1, 3 and 6 months

Net buying
1 month: +0.8%
3 months: +2.9%
6 months: +6.1%
Net selling
1 month: -1.2%
3 months: -2.6%
6 months: -3.8%

Illustrative example with simulated data. These results do not describe this company.

What follows months of insider activity?

Compare monthly net buying and selling with subsequent price movements. Signals Pro quantifies the observed relationship and shows how much evidence supports it.

  • Rank association at the same month and after 1, 3 and 6 months
  • Median price changes after net buying and net selling
  • Sample sizes and evidence levels, without implying causality
Explore Signals Pro

Public filings

Open any row to inspect the regulatory record and its transactions.

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.

DateInsiderRoleTotal reported valueOpen
20 Mar 2024Gunnar TelhammarEkonomichef/finanschef/finansdirektörBuy

SEK 34,650.00

Buy/sale net: SEK 34,650.00

Open
20 Mar 2024BioFinans ABNot availableSell

SEK 34,650.00

Buy/sale net: -SEK 34,650.00

Open
1 Mar 2024Stefan SchedingStyrelseledamotBuy

SEK 52,389.90

Buy/sale net: SEK 52,389.90

Open
11 Dec 2023Freltec ApSNot availableDirection unavailable

Not available

Buy/sale net: Not available

Open
3 Dec 2023Thomas LaurellStyrelseledamotDirection unavailable

Not available

Buy/sale net: Not available

Open
2 Dec 2023Stefan SchedingStyrelseledamotDirection unavailable

Not available

Buy/sale net: Not available

Open
23 Nov 2023Thomas LaurellStyrelseledamotDirection unavailable

Not available

Buy/sale net: Not available

Open
22 Nov 2023Stefan SchedingStyrelseledamotDirection unavailable

Not available

Buy/sale net: Not available

Open

Gunnar Telhammar

20 Mar 2024
Buy

Gross reported

SEK 34,650.00

Evidence

BioFinans AB

20 Mar 2024
Sell

Gross reported

SEK 34,650.00

Evidence

Stefan Scheding

1 Mar 2024
Buy

Gross reported

SEK 52,389.90

Evidence

Freltec ApS

11 Dec 2023
Direction unavailable

Gross reported

Not available

Evidence

Thomas Laurell

3 Dec 2023
Direction unavailable

Gross reported

Not available

Evidence

Stefan Scheding

2 Dec 2023
Direction unavailable

Gross reported

Not available

Evidence

Thomas Laurell

23 Nov 2023
Direction unavailable

Gross reported

Not available

Evidence

Stefan Scheding

22 Nov 2023
Direction unavailable

Gross reported

Not available

Evidence

People and insiders

Filings in the last 12 months refer to this company. Luck factor covers the insider’s overall activity; timing uses episodes in this company.

Signals are not available for this disclosure jurisdiction.

InsiderFilings · 12 monthsLuck factorHit rateEpisodesTiming detail
BioFinans ABSource role not reported
0UnavailableUnavailable
Freltec ApSSource role not reported
0UnavailableUnavailable
Gunnar TelhammarEkonomichef/finanschef/finansdirektör
0UnavailableUnavailable
Stefan SchedingStyrelseledamot
0UnavailableUnavailable
Thomas LaurellStyrelseledamot
0UnavailableUnavailable
Torsten FreltoftVerkställande direktör (VD)
0UnavailableUnavailable

Evidence

Open a filing in the activity ledger to inspect its transactions, original regulatory document and source provenance.

Activity